The dentate gyrus neurogenesis: A therapeutic target for Alzheimer's disease

Acta Neuropathologica

Volumn 105, Issue 3, 2003, Pages 225-232

  Tatebayashi, Yoshitaka ^a,b   Lee, Moon H ^a   Li, Liang ^a   Iqbal, Khalid ^a   Grundke Iqbal, Inge ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Alzheimer's disease; Dentate gyrus; Microtubule associated protein 2; Neural progenitor cells; Neurogenesis; Tau

Indexed keywords

CEREBROLYSIN; FIBROBLAST GROWTH FACTOR 2; MICROTUBULE ASSOCIATED PROTEIN 2; TAU PROTEIN; AMINO ACID; MICROTUBULE ASSOCIATED PROTEIN; NEUROPROTECTIVE AGENT;

ADULT; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL POLARITY; COGNITION; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; DOSE RESPONSE; FEMALE; HIPPOCAMPUS; MAZE TEST; MOOD; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; NEUROTROPISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; STEM CELL; ANIMAL; CYTOLOGY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMINO ACIDS; ANIMALS; APOPTOSIS; AXONS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; DENTATE GYRUS; FEMALE; FIBROBLAST GROWTH FACTOR 2; IMMUNOHISTOCHEMISTRY; MAZE LEARNING; MICROTUBULE-ASSOCIATED PROTEINS; NEUROPROTECTIVE AGENTS; RATS; STEM CELLS; TAU PROTEINS;

EID: 0037362773     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-002-0636-3     Document Type: Article

References (42)

1. Anderson KV (1998) Pinning down positional information: dorsal-ventral polarity in the Drosophila embryo. Cell 95:439-442
2. Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I (1989) Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28:1737-1743
3. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Backman L (1999) The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 53:1998-2002
4. Binder LI, Frankfurter A, Rebhun LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101: 1371-1378
5. Brown ES, Rush AJ, McEwen BS (1999) Hippocampal remodeling and damage by corticosteroids: implications for mood disorder. Neuropsychopharmacology 21:474-484
6. Craig AM, Banker G (1994) Neuronal polarity. Annu Rev Neurosci 17:267-310
7. Cummings BJ, Su JH, Cotman CW (1993) Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease. Exp Neurol 124:315-325
8. Eclancher F, Kehrli P, Labourdette G, Sensenbrenner M (1996) Basic fibroblast growth factor (bFGF) injection activates the glial reaction in the injured adult rat brain. Brain Res 737: 201-214
9. Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Noedborg C, Peterson DA, Gage FH (1998) Neurogenesis in the adult human bippocampus. Nat Med 4:1313-1317
10. Evans DA, Hebert LE, Beckett LA, Scherr PA, Albert MS, Chown MJ, Pilgrim DM, Taylor JO (1997) Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol 54:1399-1405
11. Fahnestock M, Michalski B, Xu B, Coughlin MD (2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 18:210-220
12. Flaumenhaft R, Rifkin DB (1992) The extracellular regulation of growth factor action. Mol Biol Cell. 3:1057-1065
13. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I (1988) A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am J Pathol 130:393-400
14. Frautschy SA, Walicke PA, Baird A (1991) Localization of basic fibroblast growth factor and its mRNA after CNS injury. Brain Res 553:291-299
15. Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST, Ray J (1995) Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci USA 92:11879-11883
16. Gonzalez AM, Buscaglia M, Ong M, Baird A (1990) Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol 110:753-765
17. Gould E, Beylin A, Tanapat P, Reeves, A, Shors TJ (1999) Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 2:260-265
18. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 93:4913-4917
19. Hock C, Heese K, Hulette C, Rosenberg C, Otten U (2000) Region-specific neurotrophin imbalances in Alzheimer disease. Arch Neurol 57:846-851
20. Jacobs BL, Praag H, Gage FH (2000) Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 5:262-269
21. Jan YN, Jan LY (2000) Polarity in cell division: what frames thy fearful asymmetry? Cell 100:599-602
22. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisen J (1999) Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96:25-34
23. Johe KK, Hazel TG, Muller T, Dugich-Djordjevic MM, McKay RDG (1996) Single factors direct the differentiation of stem cells from fetal and adult central nervous system. Genes Dev 10:3129-3140
24. Kato M, Wang H, Kainulainen V, Fitzgerald ML, Ledbetter S, Ornitz DM, Bernfield M (1998) Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med 4:691-697
25. Kempermann G, Kuhn HG, Gage FH (1997) More hippocampal neurons in adult mice living in an enriched environment. Nature 386:493-495
26. Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH (1997) Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci 15:5820-5829
27. Lee MH, Rabe A (1998) Protective effects of fetal neocortical transplants on cognitive function and neuron size in rats with congenital micrencephaly. Behav Brain Res 90:147-156
28. Logan A, Frautschy SA, Gonzalez AM, Baird A (1992) A time course for the focal elevation of synthesis of fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury. J Neurosci 12:3828-3837
29. Magavi SS, Leavitt BR, Macklis JD (2000) Induction of neurogenesis in the neocortex of adult mice. Nature 405:951-955
30. Marcus EA, Kintner C, Harris W (1998) The role of GSK3β in regulating neuronal differentiation in Xenopus laevis. Mol Cell Neurosci 12:269-280
31. Masliah E, Mallory M, Ge N, Alford M, Beinbergs I, Roses AD (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 136:107-122
32. Masliah E, Armasolo F, Veinbergs I, Mallory M, Samuel W (1999) Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Pharmacol Biochem Behav 62:239-245
33. Nilsson M, Perfilieva E, Johansson U, Johansson U, Orwar O, Erikson PS (1999) Enriched environment increases neurogenesis in the adult rat dentate gyrus and improves spatial memory. J Neurobiol 39:569-578
34. Pei J-J, Tanaka T, Tung CT, Braak E, Iqbal K, Grundke-Iqbal I (1997) Distribution, levels and activity of glycogen synthase kinase-3 in the Alzheimer Disease brain. J Neuropathol Exp Neurol 56: 70-78
35. Ruel L, Bourouis M, Heitzler P, Pantesco V, Simpson P (1993) Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch. Nature 362:557-560
36. Rüther E, Ritter R, Apecechea M, Freytag S, Windisch M (1994) Efficacy of the peptidergic nootropic drug Cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT). Pharmacopsychiatry 27:32-40
37. Rüther E, Ritter R, Apecechea M, Freytag S, Gmeinbauer R, Windisch M (2000) Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy. J Neural Transm 107:815-829
38. Stopa EG, Gonzalez AM, Chorsky R, Corona RJ, Alzarez J, Bird ED, Baird A (1990) Basic fibroblast growth factor in Alzheimer's disease. Biochem Biophys Res Commun 171:690-696
39. Tatebayashi Y, Iqbal K, Grundke-Iqbal I (1999) Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus. J Neurosci 19:5245-5254
40. Tsujio I, Tanaka T, Kudo T, Nishikawa T, Shinozaki K, Grundke-Iqbal I, Iqbal K, Takeda M (2000) Inactivation of glycogen synthase kinase-3 by protein kinase C delta: implications for regulation of tau phosphorylation. FEBS Lett 469: 111-117
41. Wang Y, Sheen VL, Macklis JD (1998) Cortical interneurons upregulate neurotrophins in vivo in response to targeted apoptotic degeneration of neighboring pyramidal neurons. Exp Neurol 154:389-402
42. Young D, Lawlor PA, Leone P, Dragunow M, During MJ (1999) Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med 5:448-453